AJOB ARTICLEInFOCUS
The Genetic Difference Principle
In the newly emerging debates about genetics and justice three distinct principles have begun to emerge concerning what the distributive aim of genetic interventions should be. These principles are: genetic equality, a genetic decent minimum, and the genetic difference principle. In this paper, I examine the rationale of each of these principles and argue that genetic equality and a genetic decent minimum are ill-equipped to tackle what I call the currency problem and the problem of weight. The genetic difference principle is the most promising of the three principles and I develop this principle so that it takes seriously the concerns of just health care and distributive justice in general. Given the strains on public funds for other important social programmes, the costs of pursuing genetic interventions and the nature of genetic interventions, I conclude that a more lax interpretation of the genetic difference principle is appropriate. This interpretation stipulates that genetic inequalities should be arranged so that they are to the greatest reasonable benefit of the least advantaged. Such a proposal is consistent with prioritarianism and provides some practical guidance for non-ideal societies–that is, societies that do not have the endless amount of resources needed to satisfy every requirement of justice.
by Colin Farrelly
FEATURE ARTICLES
Women Should Be Wary of Genetic Risk Ads
TV commercials exploit fear of breast cancer in the guise of education.
by Arthur L. Caplan
Toward a New Vocabulary of Human Genetic Variation
by Pamela L. Sankar, Mildred K. Cho
If Gene Therapy Is the Cure, What Is the Disease?
by Arthur L. Caplan
Ethical Issues in Genetics in the Next 100 Years
by Glenn McGee
Reproductive Genetics and Gender Justice
by Mary B. Mahowald More Articles... |
IN THE NEWS deCODE Files for Bankruptcy
Nov 17 (The Scientist) Iceland-based genomics pioneer deCODE announced this morning (November 17) that it has filed for bankruptcy. It will sell some of its holdings, but plans to continue operating its business and managing its properties as it does now. Family History Can Hint at How the Future Will Shape Up
Oct 27 (Washington Post) I used to rebel against the idea that we all become our mothers. But lately I find it awfully hard to deny. When four generations sat around my dinner table a few weeks back, I saw not only that am I the spitting image of both my mom and my grandmother, but also that this inheritance has also turned up everywhere from my 3-year-old's hazel eyes to my 6-month-old's dimples. We all have the same body type, sensitive skin and dark circles under our eyes -- even the kids! -- and left-handedness clearly runs in the family as well. As genetic testing races ahead, doctors are left behind
Oct 26 (Los Angeles Times) Genetic tests that can help predict and refine a patient's response to drug therapy may be the first big thing in personalized medicine. But the vast majority of physicians doesn't know how to use them, a new survey finds. Is it Worth Testing Your Genes?
Oct 21 (USA Today) Peter Orszag, the 40-year-old head of the White House Office of Management and Budget, is reported to drink so much tea, hot and iced, that he took a genetic test to see if his body could metabolize his voluminous intake of caffeine. I.B.M. Joins Pursuit of $1,000 Personal Genome
Oct 06 (New York Times) One of the oldest names in computing is joining the race to sequence the genome for $1,000. On Tuesday, I.B.M. plans to give technical details of its effort to reach and surpass that goal, ultimately bringing the cost to as low as $100, making a personal genome cheaper than a ticket to a Broadway play. More News... |
|
SUBCRIBE TO AJOB